Starlit Pharma Ceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.50 Cr
as on 10-12-2024
- Paid Up Capital ₹ 3.41 Cr
as on 10-12-2024
- Company Age 32 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -6.87%
(FY 2023)
- Profit -33.62%
(FY 2023)
- Ebitda 101.24%
(FY 2023)
- Net Worth 0.16%
(FY 2023)
- Total Assets -0.37%
(FY 2023)
About Starlit Pharma Ceuticals
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 Cr and a paid-up capital of Rs 3.41 Cr, as per Ministry of Corporate Affairs (MCA) records.
Manoj Jain and Rajesh Jain serve as directors at the Company.
- CIN/LLPIN
U24234WB1992PTC054185
- Company No.
054185
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jan 1992
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Starlit Pharma Ceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Jain  | Director | 06-Aug-1994 | Current |
| Rajesh Jain | Director | 29-May-2006 | Current |
Financial Performance of Starlit Pharma Ceuticals.
Starlit Pharma Ceuticals Pvt Ltd, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.87% decrease. The company also saw a substantial fall in profitability, with a 33.62% decrease in profit. The company's net worth moved up by a moderate rise of 0.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Starlit Pharma Ceuticals?
In 2023, Starlit Pharma Ceuticals had a public holding of 99.95%. The company had 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Starlit Pharma Ceuticals?
Unlock and access historical data on people associated with Starlit Pharma Ceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Starlit Pharma Ceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Starlit Pharma Ceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
